Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01597336 · ClinicalTrials.gov registry record · NA
Treatment of Abdominal Abscesses With or Without Fibrinolysis
A NA study, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT01597336: Completed NA study, sponsored by Children's Mercy Hospital Kansas City.
NCT01597336 is a NA study that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 92 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01597336, a NA study, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the utility of fibrinolysis when draining an abdominal abscess as defined by length of stay after drainage.
Primary Outcome
Length of time required for meeting discharge criteria
Interventions
- PROCEDURE Tissue plasminogen activator abscess flush
- PROCEDURE Saline flush of abscess
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-05 |
| Phase | NA |
What the finished NCT01597336 record still lists
NCT01597336 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Tissue plasminogen activator abscess flush is the first listed.
NCT01597336 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01597336 about?
NCT01597336 is a clinical study titled "Treatment of Abdominal Abscesses With or Without Fibrinolysis". The objective of this study is to evaluate the utility of fibrinolysis when draining an abdominal abscess as defined by length of stay after drainage.
What is the current status of trial NCT01597336?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2009-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01597336?
The interventions under investigation include: Tissue plasminogen activator abscess flush (PROCEDURE), Saline flush of abscess (PROCEDURE).
Who is sponsoring clinical trial NCT01597336?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01597336's enrollment target sits among peer trials
92 937th of 2000 higher than 1,062 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia